Medtronic (MDT) Jumps on Positive Preclinical Drug-Filled Stent Data

Friday, March 20, 2015

Source: Device Space

In an attempt to expand its interventional cardiology products portfolio, Medtronic plc recently revealed preclinical outcomes of its latest, groundbreaking Drug-Filled Stent (DFS), demonstrating the device's safety and efficiency, at the 64 th Annual Scientific Session of the American College of Cardiology (ACC). 

View All News »